2022 PRiME Fellowship Awardees Announced

Congratulations to the winners of the 2022 PRiME Fellowship Competition. PRiME Fellows represent the next generation of scientific leaders, testing bold ideas that enable interdisciplinary research in precision medicine. The 2022 cohort combine expertise across the four PRiME Faculties, applying molecular biology, genomics, computational biology, and bioengineering toward diagnostic and therapeutic solutions.

Projects range from identifying novel therapeutics for cancer, atherosclerosis, and muscle disease, to designing DNA nanotechnology and omics approaches, to creating a novel intranasal vaccine for COVID-19. The annual competition funds PhD students or postdoctoral fellows, with co-supervision by PRiME investigators across the Faculties of Arts & Science, Applied Science & Engineering, Medicine, and Pharmacy.

The 2022 cohort: Rebecca Allan (Gunning & Salmena) on inhibitors for fibrolamellar hepatocellular carcinoma; Travis Douglas (Chou & Khan) on DNA-nanoparticle macrophage polarization; Yechen Hu (Wheeler & Gilbert) on muscle stem-cell multi-omics; Funing Lin (Batey & Houry) on ClpP-targeting anticancer therapeutics; Dominic Owens (Arrowsmith & Bader) on ribosome biogenesis in cancer; Sarah Shawky (Cummins & Radisic) on heart-on-a-chip anti-atherosclerotic proteins; Daniel Tabet (Roth & Garton) on modeling the LDL–LDLR interaction; and Andrew Varley (Li, Gray-Owen & Gommerman) on a circular-RNA intranasal COVID-19 vaccine.